93 318 Pill - orange round, 8mm
Pill with imprint 93 318 is Orange, Round and has been identified as Diltiazem Hydrochloride 30 mg. It is supplied by Teva Pharmaceuticals USA.
Diltiazem is used in the treatment of Atrial Fibrillation; Atrial Flutter; Angina Pectoris Prophylaxis; High Blood Pressure; Heart Failure and belongs to the drug classes calcium channel blockers, group IV antiarrhythmics. Risk cannot be ruled out during pregnancy. Diltiazem 30 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 93 318
Diltiazem Hydrochloride
- Imprint
- 93 318
- Strength
- 30 mg
- Color
- Orange
- Size
- 8.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Calcium channel blockers, Group IV antiarrhythmics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA
- Inactive Ingredients
-
lactose monohydrate,
magnesium stearate,
polysorbate 80,
povidone k90,
titanium dioxide,
FD&C Yellow No. 6
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00093-0318 | Teva Pharmaceuticals USA, Inc. |
| 63739-0079 (Discontinued) | McKesson Packaging Services |
Related images for "93 318"
More about diltiazem
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (186)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: calcium channel blockers
- Breastfeeding
Patient resources
- Diltiazem drug information
- Diltiazem (Intravenous) (Advanced Reading)
- Diltiazem Long-Acting Capsules
- Diltiazem Long-Acting Tablets
- Diltiazem 12-Hour Sustained-Release Capsules
Other brands
Cardizem, Cartia XT, Cardizem CD, Dilt-XR, ... +7 more
Professional resources
- DilTIAZem monograph
- Diltiazem (FDA)
- Diltiazem CD (FDA)
- Diltiazem Extended Release Tablets (FDA)
- Diltiazem Injection (FDA)
- Diltiazem Tablets (FDA)
Other brands
Cardizem, Cartia XT, Cardizem CD, Dilt-XR, ... +6 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
